205 related articles for article (PubMed ID: 15499185)
1. Functional regions of organic cation/carnitine transporter OCTN2 (SLC22A5): roles in carnitine recognition.
Inano A; Sai Y; Kato Y; Tamai I; Ishiguro M; Tsuji A
Drug Metab Pharmacokinet; 2004 Jun; 19(3):180-9. PubMed ID: 15499185
[TBL] [Abstract][Full Text] [Related]
2. Mutations in novel organic cation transporter (OCTN2), an organic cation/carnitine transporter, with differential effects on the organic cation transport function and the carnitine transport function.
Seth P; Wu X; Huang W; Leibach FH; Ganapathy V
J Biol Chem; 1999 Nov; 274(47):33388-92. PubMed ID: 10559218
[TBL] [Abstract][Full Text] [Related]
3. Glycosylation of the OCTN2 carnitine transporter: study of natural mutations identified in patients with primary carnitine deficiency.
Filippo CA; Ardon O; Longo N
Biochim Biophys Acta; 2011 Mar; 1812(3):312-20. PubMed ID: 21126579
[TBL] [Abstract][Full Text] [Related]
4. Tyrosine residues affecting sodium stimulation of carnitine transport in the OCTN2 carnitine/organic cation transporter.
Amat di San Filippo C; Longo N
J Biol Chem; 2004 Feb; 279(8):7247-53. PubMed ID: 14665638
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological and pathophysiological roles of carnitine/organic cation transporters (OCTNs: SLC22A4, SLC22A5 and Slc22a21).
Tamai I
Biopharm Drug Dispos; 2013 Jan; 34(1):29-44. PubMed ID: 22952014
[TBL] [Abstract][Full Text] [Related]
6. Functional domains in the carnitine transporter OCTN2, defective in primary carnitine deficiency.
Amat di San Filippo C; Wang Y; Longo N
J Biol Chem; 2003 Nov; 278(48):47776-84. PubMed ID: 14506273
[TBL] [Abstract][Full Text] [Related]
7. Studies on functional sites of organic cation/carnitine transporter OCTN2 (SLC22A5) using a Ser467Cys mutant protein.
Ohashi R; Tamai I; Inano A; Katsura M; Sai Y; Nezu J; Tsuji A
J Pharmacol Exp Ther; 2002 Sep; 302(3):1286-94. PubMed ID: 12183691
[TBL] [Abstract][Full Text] [Related]
8. Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2.
Tamai I; Ohashi R; Nezu J; Yabuuchi H; Oku A; Shimane M; Sai Y; Tsuji A
J Biol Chem; 1998 Aug; 273(32):20378-82. PubMed ID: 9685390
[TBL] [Abstract][Full Text] [Related]
9. Involvement of carnitine/organic cation transporter OCTN2 (SLC22A5) in distribution of its substrate carnitine to the heart.
Iwata D; Kato Y; Wakayama T; Sai Y; Kubo Y; Iseki S; Tsuji A
Drug Metab Pharmacokinet; 2008; 23(3):207-15. PubMed ID: 18574325
[TBL] [Abstract][Full Text] [Related]
10. Expression of OCTN2 and OCTN3 in the apical membrane of rat renal cortex and medulla.
Cano MM; Calonge ML; Ilundain AA
J Cell Physiol; 2010 May; 223(2):451-9. PubMed ID: 20112288
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological manipulation of L-carnitine transport into L6 cells with stable overexpression of human OCTN2.
Todesco L; Bur D; Brooks H; Török M; Landmann L; Stieger B; Krähenbühl S
Cell Mol Life Sci; 2008 May; 65(10):1596-608. PubMed ID: 18408886
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of OCTN2-mediated transport of carnitine by etoposide.
Hu C; Lancaster CS; Zuo Z; Hu S; Chen Z; Rubnitz JE; Baker SD; Sparreboom A
Mol Cancer Ther; 2012 Apr; 11(4):921-9. PubMed ID: 22389472
[TBL] [Abstract][Full Text] [Related]
13. Functional expression of organic cation/carnitine transporter 2 (OCTN2/SLC22A5) in human brain capillary endothelial cell line hCMEC/D3, a human blood-brain barrier model.
Okura T; Kato S; Deguchi Y
Drug Metab Pharmacokinet; 2014; 29(1):69-74. PubMed ID: 23877104
[TBL] [Abstract][Full Text] [Related]
14. Molecular and physiological evidence for multifunctionality of carnitine/organic cation transporter OCTN2.
Ohashi R; Tamai I; Nezu Ji J; Nikaido H; Hashimoto N; Oku A; Sai Y; Shimane M; Tsuji A
Mol Pharmacol; 2001 Feb; 59(2):358-66. PubMed ID: 11160873
[TBL] [Abstract][Full Text] [Related]
15. Mutations of OCTN2, an organic cation/carnitine transporter, lead to deficient cellular carnitine uptake in primary carnitine deficiency.
Tang NL; Ganapathy V; Wu X; Hui J; Seth P; Yuen PM; Wanders RJ; Fok TF; Hjelm NM
Hum Mol Genet; 1999 Apr; 8(4):655-60. PubMed ID: 10072434
[TBL] [Abstract][Full Text] [Related]
16. Caveolin-1--a novel interacting partner of organic cation/carnitine transporter (Octn2): effect of protein kinase C on this interaction in rat astrocytes.
Czeredys M; Samluk Ł; Michalec K; Tułodziecka K; Skowronek K; Nałęcz KA
PLoS One; 2013; 8(12):e82105. PubMed ID: 24349196
[TBL] [Abstract][Full Text] [Related]
17. Functional genetic diversity in the high-affinity carnitine transporter OCTN2 (SLC22A5).
Urban TJ; Gallagher RC; Brown C; Castro RA; Lagpacan LL; Brett CM; Taylor TR; Carlson EJ; Ferrin TE; Burchard EG; Packman S; Giacomini KM
Mol Pharmacol; 2006 Nov; 70(5):1602-11. PubMed ID: 16931768
[TBL] [Abstract][Full Text] [Related]
18. Role of Na+/L-carnitine transporter (OCTN2) in renal handling of pivaloylcarnitine and valproylcarnitine formed during pivalic acid-containing prodrugs and valproic acid treatment.
Ohnishi S; Okamura N; Sakamoto S; Hasegawa H; Norikura R; Kanaoka E; Takahashi K; Horie K; Sakamoto K; Baba T
Drug Metab Pharmacokinet; 2008; 23(4):293-303. PubMed ID: 18762717
[TBL] [Abstract][Full Text] [Related]
19. Organic cation/carnitine transporter OCTN2 (Slc22a5) is responsible for carnitine transport across apical membranes of small intestinal epithelial cells in mouse.
Kato Y; Sugiura M; Sugiura T; Wakayama T; Kubo Y; Kobayashi D; Sai Y; Tamai I; Iseki S; Tsuji A
Mol Pharmacol; 2006 Sep; 70(3):829-37. PubMed ID: 16754783
[TBL] [Abstract][Full Text] [Related]
20. Na(+)-coupled transport of L-carnitine via high-affinity carnitine transporter OCTN2 and its subcellular localization in kidney.
Tamai I; China K; Sai Y; Kobayashi D; Nezu J; Kawahara E; Tsuji A
Biochim Biophys Acta; 2001 Jun; 1512(2):273-84. PubMed ID: 11406104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]